Dana A Kelly1, Michael Seidenberg1, Katherine Reiter2, Kristy A Nielson2, John L Woodard3, J Carson Smith4, Sally Durgerian5, Stephen M Rao6. 1. Department of Psychology, Rosalind Franklin University of Medicine and Science. 2. Department of Psychology, Marquette University. 3. Department of Psychology, Wayne State University. 4. Department of Kinesiology, School of Public Health, University of Maryland. 5. BrainDataDriven LLC. 6. Schey Center for Cognitive Neuroimaging, Cleveland Clinic.
Abstract
OBJECTIVE: The apolipoprotein E (APOE) ε4 allele is the most important genetic risk factor for late-onset Alzheimer's disease. Many ε4 carriers, however, never develop Alzheimer's disease. The purpose of this study is to characterize the variability in phenotypic expression of the ε4 allele, as measured by the longitudinal trajectory of cognitive test scores and MRI brain volumes, in cognitively intact elders. METHOD: Healthy older adults, ages 65-85, participated in a 5-year longitudinal study that included structural MRI and cognitive testing administered at baseline and at 1.5 and 5 years postenrollment. Participants included 22 ε4 noncarriers, 15 ε4 carriers who experienced a decline in cognition over the 5-year interval, and 11 ε4 carriers who remained cognitively stable. RESULTS: No baseline cognitive or volumetric group differences were observed. Compared to noncarriers, declining ε4 carriers had significantly greater rates of atrophy in left (p = .001, Cohen's d = .691) and right (p = .003, d = .622) cortical gray matter, left (p = .003, d = .625) and right (p = .020, d = .492) hippocampi, and greater expansion of the right inferior lateral ventricle (p < .001, d = .751) over 5 years. CONCLUSIONS: This study illustrates the variability in phenotypic expression of the ε4 allele related to neurodegeneration. Specifically, only those individuals who exhibited longitudinal declines in cognitive function experienced concomitant changes in brain volume. Future research is needed to better understand the biological and lifestyle factors that may influence the expression of the ε4 allele. (PsycINFO Database Record (c) 2018 APA, all rights reserved).
OBJECTIVE: The apolipoprotein E (APOE) ε4 allele is the most important genetic risk factor for late-onset Alzheimer's disease. Many ε4 carriers, however, never develop Alzheimer's disease. The purpose of this study is to characterize the variability in phenotypic expression of the ε4 allele, as measured by the longitudinal trajectory of cognitive test scores and MRI brain volumes, in cognitively intact elders. METHOD: Healthy older adults, ages 65-85, participated in a 5-year longitudinal study that included structural MRI and cognitive testing administered at baseline and at 1.5 and 5 years postenrollment. Participants included 22 ε4 noncarriers, 15 ε4 carriers who experienced a decline in cognition over the 5-year interval, and 11 ε4 carriers who remained cognitively stable. RESULTS: No baseline cognitive or volumetric group differences were observed. Compared to noncarriers, declining ε4 carriers had significantly greater rates of atrophy in left (p = .001, Cohen's d = .691) and right (p = .003, d = .622) cortical gray matter, left (p = .003, d = .625) and right (p = .020, d = .492) hippocampi, and greater expansion of the right inferior lateral ventricle (p < .001, d = .751) over 5 years. CONCLUSIONS: This study illustrates the variability in phenotypic expression of the ε4 allele related to neurodegeneration. Specifically, only those individuals who exhibited longitudinal declines in cognitive function experienced concomitant changes in brain volume. Future research is needed to better understand the biological and lifestyle factors that may influence the expression of the ε4 allele. (PsycINFO Database Record (c) 2018 APA, all rights reserved).
Authors: Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale Journal: Neuron Date: 2002-01-31 Impact factor: 17.173
Authors: M Seidenberg; L Guidotti; K A Nielson; J L Woodard; S Durgerian; P Antuono; Q Zhang; S M Rao Journal: Neurology Date: 2009-08-25 Impact factor: 9.910
Authors: J Carson Smith; Melissa A Lancaster; Kristy A Nielson; John L Woodard; Michael Seidenberg; Sally Durgerian; Ken Sakaie; Stephen M Rao Journal: Neuroimage Date: 2015-08-08 Impact factor: 6.556
Authors: J Carson Smith; Kristy A Nielson; John L Woodard; Michael Seidenberg; Sally Durgerian; Kathleen E Hazlett; Christina M Figueroa; Cassandra C Kandah; Christina D Kay; Monica A Matthews; Stephen M Rao Journal: Front Aging Neurosci Date: 2014-04-23 Impact factor: 5.750
Authors: Lauren N Koenig; Pamela LaMontagne; Matthew F Glasser; Randall Bateman; David Holtzman; Igor Yakushev; Jasmeer Chhatwal; Gregory S Day; Clifford Jack; Catherine Mummery; Richard J Perrin; Brian A Gordon; John C Morris; Joshua S Shimony; Tammie L S Benzinger Journal: Neurobiol Aging Date: 2021-09-15 Impact factor: 4.673
Authors: Caitlin S Latimer; Katherine L Lucot; C Dirk Keene; Brenna Cholerton; Thomas J Montine Journal: Annu Rev Pathol Date: 2021-01-24 Impact factor: 23.472